假禾谷镰孢咯菌腈抗性突变体的生存适合度及抗药性机制

    Fitness and resistance mechanism of Fusarium pseudograminearum mutants resistant to fludioxonil

    • 摘要: 主要由假禾谷镰孢(Fusarium pseudograminearum)引起的小麦茎基腐病(Fusarium crown rot, FCR)现已成为黄淮海麦区的二类病害,苯基吡咯类杀菌剂咯菌腈是防治小麦茎基腐病的主要药剂。已有的研究表明:假禾谷镰孢对咯菌腈的抗药性主要与双组分组氨酸激酶FpOS1基因的表达水平有关,但并未深入研究其它FpOS基因突变与咯菌腈敏感性的关系,也并未开展FpOS蛋白和咯菌腈结合的分子模拟研究。鉴于此,本研究通过对4株假禾谷镰孢敏感性菌株进行药剂驯化,获得了16株抗药性性状可稳定遗传的突变体,抗性倍数为633.73~8617.07。与亲本菌株相比,抗性突变体的菌丝生长速率、产孢量及致病性均显著下降;抗性突变体对离子胁迫、糖胁迫、氧胁迫均较亲本菌株更敏感,细胞壁和细胞膜的完整性程度均较亲本菌株低。咯菌腈与戊唑醇(tebuconazole)、氟唑菌酰羟胺(pydiflumetofen)无交互抗性,但与吡唑醚菌酯(pyraclostrobin)和异菌脲(iprodione)分别存在微弱的或中等的正交互抗性。咯菌腈可显著促进亲本菌株的甘油合成并抑制脱氧雪腐镰刀菌烯醇(deoxynivalenol,DON) 产生,而对抗性突变体的调控作用显著减弱。抗性突变体的FpOS1FpOS4FpOS5 基因均存在突变位点,FpOS1基因的突变频率较低,FpOS2 基因未检测到突变;分子对接结果表明,FpOS4及FpOS5氨基酸替换可显著降低咯菌腈与靶标蛋白的结合力。假禾谷镰孢对咯菌腈存在中等水平的抗性风险,FpOS4FpOS5基因的点突变可能是其抗性产生的重要分子机制之一,推测其通过降低药剂与靶标蛋白的结合力而实现。本研究进一步明确了假禾谷镰孢对咯菌腈抗性的分子机制,为咯菌腈在小麦茎基腐病防治中的合理应用提供了科学依据。

       

      Abstract: Fusarium crown rot (FCR), predominantly caused by Fusarium pseudograminearum, has been listed as a Category II disease in six provinces of China, posing a significant threat to wheat production. The phenylpyrrole fungicide fludioxonil is a key agent for FCR control. Previous studies indicated that resistance to fludioxonil in F. pseudograminearum is primarily associated with altered expression levels of the FpOS1 gene, which encodes a hybrid histidine kinase. However, the roles of mutations in other FpOS genes and the molecular interactions between FpOS proteins and fludioxonil remain elusive. To address these gaps, we generated 16 fludioxonil-resistant mutants with heritable resistance traits by in vitro selection of four sensitive F. pseudograminearum isolates. These mutants exhibited high resistance levels, with resistance factors (RF) ranging from 633.73 to 8617.07. Compared to their parental isolates, the resistant mutants showed significantly reduced mycelial growth rate, sporulation capacity, and pathogenicity. They were also more sensitive to ionic, osmotic, and oxidative stresses and displayed compromised cell wall and membrane integrity. Fludioxonil demonstrated no cross-resistance with tebuconazole or pydiflumetofen; however, it exhibited weak positive cross-resistance to pyraclostrobin and moderate positive cross-resistance to iprodione. Fludioxonil treatment significantly promoted glycerol synthesis and inhibited deoxynivalenol (DON) production in parental isolates, whereas these regulatory effects were markedly attenuated in the resistant mutants. Mutation analysis identified mutation sites in FpOS1, FpOS4, and FpOS5 genes, with a lower mutation frequency in FpOS1 and no mutations detected in FpOS2. Molecular docking indicated that amino acid substitutions in FpOS4 and FpOS5 significantly reduced the binding affinity of fludioxonil to these target proteins. In conclusion, F. pseudograminearum poses a moderate risk of resistance to fludioxonil. Point mutations in FpOS4 and FpOS5 genes emerge as key molecular drivers of resistance, likely by diminishing the binding affinity between the fungicide and its proteins. This study clarifies the molecular basis of fludioxonil resistance in F. pseudograminearum and provides a scientific rationale for the judicious use of this fungicide in managing FCR.

       

    /

    返回文章
    返回